Luc Cabel

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Luc Cabel, Francesca Riva, Vincent Servois et al. · Annals of Oncology · 2017 · 337 citations

Life Sciences, Immunology, Oncology +17

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué et al. · JAMA Oncology · 2020 · 178 citations · Full text

Medicine, Oncology, Chemotherapy +16

Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

Clarice S. Groeneveld, Jacqueline Fontugne, Luc Cabel et al. · European Journal of Cancer · 2021 · 153 citations

Medicine, Oncology, Urology +10

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area

Perrine Vuagnat, Maxime Frélaut, Toulsie Ramtohul et al. · Breast Cancer Research · 2020 · 125 citations · Full text

Medicine, Oncology, Radiology +12

Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers

Toulsie Ramtohul, Lounes Djerroudi, Émilie Lissavalid et al. · Radiology · 2023 · 116 citations

Medicine, Oncology, Radiology +17